Colossal Biosciences announces new AI platform to help accelerate de-extinction efforts
Colossal announced a new AI platform to help accelerate its de-extinction efforts and Peter Diamandis has launched a new fund to back startups who use it.
Colossal Biosciences has unveiled an AI platform called GenoMorph to expedite its de-extinction endeavors, according to an exclusive report by TechCrunch. The platform employs 3D morphology, comparative genomics, and developmental biology to pinpoint genes for editing in limited gene data scenarios, such as with the dodo bird. Colossal CEO Ben Lamm explained that the AI system identifies regions of DNA active during bird development, predicting which genetic switches contributed to the dodo's distinctive features.
With only one Dodo genome available, compared to 100 for the woolly mammoth, GenoMorph aims to pinpoint the critical genetic differences for physical traits. The company has also developed a method using lipid nanoparticles to deliver gene-editing tools directly into developing bird embryos, allowing for quicker observation of genetic changes.
Colossal is optimistic about the convergence of their technologies, stating that GenoMorph will help them test their predictions in the lab.
Written by urgent.news from TechCrunch's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
